Maxipime and Confusional state - a phase IV clinical study of FDA data
Summary:
Confusional state is found among people who take Maxipime, especially for people who are male, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Maxipime and have Confusional state. It is created by eHealthMe based on reports of 4,074 people who have side effects when taking Maxipime from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
4,074 people reported to have side effects when taking Maxipime.
Among them, 104 people (2.55%) have Confusional state.
What is Maxipime?
Maxipime has active ingredients of cefepime hydrochloride. eHealthMe is studying from 4,081 Maxipime users for its effectiveness, alternative drugs and more.
What is Confusional state?
Confusional state is found to be associated with 3,384 drugs and 3,250 conditions by eHealthMe.
Number of Maxipime and Confusional state reports submitted per year:
Time on Maxipime when people have Confusional state *:
Gender of people who have Confusional state when taking Maxipime*:
Age of people who have Confusional state when taking Maxipime *:
Common drugs people take besides Maxipime *:
Common side effects people have besides Confusional state *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Maxipime and have Confusional state?
Check whether Confusional state is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Confusional state and when was it recovered:
Expand to all the drugs that have ingredients of cefepime hydrochloride:
Alternative drugs to, pros and cons of Maxipime:
- Maxipime (4,081 reports)
Common Maxipime side effects:
- Thrombocytopenia (decrease of platelets in blood): 502 reports
- Fever: 495 reports
- Pneumonia: 453 reports
- Sepsis (a severe blood infection that can lead to organ failure and death): 346 reports
Browse all side effects of Maxipime:
a b c d e f g h i j k l m n o p q r s t u v w x y zConfusional state treatments and more:
- Confusional state (162,200 reports)
COVID vaccines that are related to Confusional state:
- Confusional state in Moderna COVID Vaccine
- Confusional state in Pfizer BioNTech Covid Vaccine
- Confusional state in Johnson and Johnson Covid Vaccine
Common drugs associated with Confusional state:
- Aspirin: 8,665 reports
- Prednisone: 6,703 reports
- Omeprazole: 6,224 reports
- Metformin: 5,869 reports
- Lyrica: 5,285 reports
- Furosemide: 5,142 reports
- Gabapentin: 5,067 reports
- Pantoprazole: 5,040 reports
- Cymbalta: 4,932 reports
- Simvastatin: 4,651 reports
All the drugs that are associated with Confusional state:
- Confusional state (3,384 drugs)
Common conditions associated with Confusional state:
- Depression: 9,369 reports
- Multiple sclerosis: 9,192 reports
- Pain: 8,527 reports
- High blood pressure: 8,095 reports
- Rheumatoid arthritis: 4,986 reports
- Parkinson's disease: 4,731 reports
All the conditions that are associated with Confusional state:
- Confusional state (3,250 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on cefepime hydrochloride (the active ingredients of Maxipime) and Maxipime (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Linzess and Photophobia - now
- Novalgin vs. Flexeril - 7 seconds ago
- Valturna and Fentanyl-100 drug interaction - 13 seconds ago
- Sulfasalazine and Trichosporon Infection - 19 seconds ago
- Atarax and Cerebral Palsy - 21 seconds ago
- Clofibrate and Stools - Watery - 24 seconds ago
- Clofibrate and Diarrhea - 24 seconds ago
- Gingival Hypertrophy and drugs of ingredients of sulfasalazine - 29 seconds ago
- Prochlorperazine Maleate and Hyperthyroidism - 34 seconds ago
- Xyzal and Cryselle drug interaction - 37 seconds ago